cisplatin analog (Granada/Sevilla)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecisplatin analog (Granada/Sevilla)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalators
TargetsDNA
Therapy Area/IndicationsOvarian NeoplasmsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Granada
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversidad de SevillaUniversity Of Granada
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A